Abstract
Bone morphogenic protein-2 (BMP-2) is the most documented member of BMP family and plays a crucial role in bone formation and growth. In this study, we systematically analyze and compare the complex crystal structures and interaction properties of BMP-2 with its cognate receptors BMPR-I/BMPR-II and with its natural antagonist crossveinless-2 (CV-2) using an integrated in silico-in vitro strategy. It is found that the antagonist-binding site is not fully overlapped with the two receptor-binding sites on BMP-2 surface; the antagonist can competitively disrupt BMP-2–BMPR-II interaction using a blocking-out-of-site manner, but has no substantial influence on BMP-2–BMPR-I interaction. Here, the antagonist-binding site is assigned as a new functional epitope armpit to differ from the traditional conformational epitope wrist and linear epitope knuckle at receptor-binding sites. Structural analysis reveals that the armpit comprises three sequentially discontinuous, structurally vicinal peptide segments, separately corresponding to a loop region and two β-strands crawling on the protein surface. The three segments cannot work independently when splitting from the protein context, but can restore binding capability to CV-2 if they are connected to a single peptide. A systematic combination of different-length polyglycine linkers between these segments obtains a series of designed single peptides, from which several peptides that can potently interact with the armpit-recognition site of CV-2 with high affinity and specificity are identified using energetic analysis and fluorescence assay; they are expected to target BMP-2–CV-2 interaction in a self-inhibitory manner.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10930-020-09937-6/MediaObjects/10930_2020_9937_Fig6_HTML.png)
Similar content being viewed by others
References
Dimitriou R, Jones E, McGonagle D, Giannoudis PV (2011) Bone regeneration: current concepts and future directions. BMC Med 9:66
Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233–241
Luo K (2017) Signaling cross talk between TGF-β/Smad and other signaling pathways. Cold Spring Harb Perspect Biol 9:a022137
Rosen V (2006) BMP and BMP inhibitors in bone. Ann N Y Acad Sci 1068:19–25
Kirsch T, Nickel J, Sebald W (2000) BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J 19:3314–3324
Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M (2003) Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 1651:60–67
Chen X, Wang H, Yang S, Zheng J, Liu X, Mao G (2020) Structure-based discovery and redesign of TGF-β1 elbow epitope recognition by its type-II receptor in hypertrophic scarring biotherapy. J Mol Recog. https://doi.org/10.1002/jmr.2881
Ali IHA, Brazil DP (2014) Bone morphogenetic proteins and their antagonists: current and emerging clinical uses. Br J Pharmacol 171:3620–3632
Fan X, **a H, Liu X, Li B, Fang J (2019) Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2. J Biosci 44:130
Zhang A, Chen Z, Yu X, Zhang L, Song Q (2020) Rational derivation of osteogenic peptides from bone morphogenetic protein-2 knuckle epitope by integrating in silico analysis and in vitro assay. Int J Pept Res Ther. https://doi.org/10.1007/s10989-020-10058-y
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242
Zhang JL, Qiu LY, Kotzsch A, Weidauer S, Patterson L, Hammerschmidt M, Sebald W, Mueller TD (2008) Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell 14:739–750
Zhou P, Yang C, Ren Y, Wang C, Tian F (2013) What are the ideal properties for functional food peptides with antihypertensive effect? A computational peptidology approach. Food Chem 141:2967–2973
Word JM, Lovell SC, Richardson JS, Richardson DC (1999) Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J Mol Biol 285:1735–1747
Anandakrishnan R, Aguilar B, Onufriev AV (2012) H++ 3.0: automating pKa prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res 40:W537–W541
Yang C, Wang C, Zhang S, Huang J, Zhou P (2015) Structural and energetic insights into the intermolecular interaction among human leukocyte antigens, clinical hypersensitive drugs and antigenic peptides. Mol Simul 41:741–751
Zhou P, Zhang S, Wang Y, Yang C, Huang J (2016) Structural modeling of HLA-B*1502 peptide carbamazepine T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome toxic epidermal necrolysis. J Biomol Struct Dyn 34:1806–1817
Gao S, Wang Y, Ji L (2020) Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers. J Recept Signal Transduct Res 10:1–8
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: and N.log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol Inf 31:114–122
Zhou P, Wang C, Tian F, Ren Y, Yang C, Huang J (2013) Biomacromolecular quantitative structure-activity relationship (BioQSAR): a proof-of-concept study on the modeling, prediction and interpretation of protein-protein binding affinity. J Comput Aided Mol Des 27:67–78
Yu H, Zhou P, Deng M, Shang Z (2014) Indirect readout in protein-peptide recognition: a different story from classical biomolecular recognition. J Chem Inf Model 54:2022–2032
Miyazono K, Kamiya Y, Morikawa M (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35–51
Lee B, Richards FM (1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55:379–400
Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774–797
Kortemme T, Kim DE, Baker D (2004) Computational alanine scanning of protein-protein interfaces. Sci STKE 2004:pl2
Zhou P, Miao Q, Yan F, Li Z, Jiang Q, Wen L, Meng Y (2019) Is protein context responsible for peptide-mediated interactions? Mol Omics 15:280–295
London N, Raveh B, Movshovitz-Attias D, Schueler-Furman O (2010) Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions? Proteins 78:3140–3149
Agrawal P, Singh H, Srivastava HK, Singh S, Kishore G, Raghava GPS (2019) Benchmarking of different molecular docking methods for protein-peptide docking. BMC Bioinform 19:S426
Acknowledgements
This work was supported by the YCH funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declared that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, Y., Jia, G., Chi, H. et al. Integrated In Silico-In Vitro Identification and Optimization of Bone Morphogenic Protein-2 Armpit Epitope as Its Antagonist Binding Site. Protein J 39, 703–710 (2020). https://doi.org/10.1007/s10930-020-09937-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-020-09937-6